Adrenalectomy for Cushing’s syndrome: do’s and don’ts

نویسندگان

  • Paduraru DN
  • Nica A
  • Carsote M
  • Valea A
چکیده

Aim. To present specific aspects of adrenalectomy for Cushing's syndrome (CS) by introducing well established aspects ("do's") and less known aspects ("don'ts"). Material and Method. This is a narrative review. Results. The "do's" for laparoscopic adrenalectomy (LA) are the following: it represents the "gold standard" for secretor and non-secretor adrenal tumors and the first line therapy for CS with an improvement of cardio-metabolic co-morbidities; the success rate depending on the adequate patients' selection and the surgeon's skills. The "don'ts" are large (>6-8 centimeters), locally invasive, malignant tumors requiring open adrenalectomy (OA). Robotic adrenalectomy is a new alternative for LA, with similar safety and conversion rate and lower pain drugs use. The "don'ts" are the following: lack of randomized controlled studies including oncologic outcome, different availability at surgical centers. Related to the sub-types of CS, the "do's" are the following: adrenal adenomas which are cured by LA, while adrenocortical carcinoma (ACC) requires adrenalectomy as first line therapy and adjuvant mitotane therapy; synchronous bilateral adrenalectomy (SBA) is useful for Cushing's disease (only cases refractory to pituitary targeted therapy), for ectopic Cushing's syndrome (cases with unknown or inoperable primary site), and for bilateral cortisol producing adenomas. The less established aspects are the following: criteria of skilled surgeon to approach ACC; the timing of surgery in subclinical CS; the need for adrenal vein catheterization (which is not available in many centers) to avoid unnecessary SBA. Conclusion. Adrenalectomy for CS is a dynamic domain; LA overstepped the former OA area. The future will improve the knowledge related to RA while the cutting edge is represented by a specific frame of intervention in SCS, children and pregnant women. Abbreviations: ACC = adrenocortical carcinoma, ACTH = Adrenocorticotropic Hormone, CD = Cushing's disease, CS = Cushing's syndrome, ECS = Ectopic Cushing's syndrome, LA = laparoscopic adrenalectomy, OA = open adrenalectomy, PA = partial adrenalectomy, RA = robotic adrenalectomy, SCS = subclinical Cushing' syndrome.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

گزارش دو مورد جراحی نابه‌جای آدرنالکتومی یک‌طرفه در دو بیمار مبتلا به کوشینگ (آدنوم هیپوفیز)

Cushing’s syndrome which is an uncommon but lethal disorder occurs due to many causes. The most common endogenous cause is Cushing’s disease or pituitary Cushing. The etiology of this disorder is an adenoma in the anterior pituitary. The most important point in the treatment of this disorder is differentiation between Cushing’s disease (pituitary) and Cushing’s syndrome (adrenal). We can differ...

متن کامل

Abnormal thyroid stimulating hormone levels: when and who to treat.

diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 2003;88:5299–306. 7 Newell-Price J, Trainer P, Perry L et al. A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 1995;43: 545–50. 8 Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. A single midnight serum cortisol measurement distinguishes Cushing’s sy...

متن کامل

SHORT COMMUNICATION Full Title: Agouti related protein (AgRP) is upregulated in Cushing’s syndrome Short title: AgRP is upregulated in Cushing’s syndrome

Alpha melanocyte stimulating hormone (α-MSH) is an agonist at the melanocortin 3 (MC3-R) and melanocortin 4 (MC4-R) receptors. α-MSH stimulates corticosterone release from rat and human adrenal cells. Patients with Cushing’s syndrome have elevated levels of serum α-MSH. Agouti related protein (AgRP) is an endogenous antagonist at the MC3-R and MC4-R and is expressed in the rat adrenal cortex. A...

متن کامل

A Long-Standing Subtle Cushing’s Syndrome Induced by a Unilateral Macronodular Adrenal Hyperplasia

Cushing’s syndrome is a clinical picture characterized by signs and symptoms associated with a prolonged exposure to inappropriately high level of the hormone cortisol. Described for the first time by Harvey Cushing in 1932, iatrogenic cause, by taking drugs, is the common condition nowadays. The most common non-iatrogenic cause of Cushing’s syndrome is Cushing’s disease, referring to a tumor (...

متن کامل

Subclinical Cushing's Syndrome and Metabolic Disorder

The concept of subclinical Cushing’s syndrome stands on the presence of adrenocorticotropic hormone-independent subclinical hypercortisolism without a clear Cushingoid phenotype and may be observed in patients with an incidentally found adrenal adenoma [1]. Kim et al. [2] found that the prevalence of subclinical Cushing’s syndrome in Korean patients with adrenal incidentaloma was 7.1% (19 of 26...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2016